Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs VINEET LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA VINEET LABORATORIES SHUKRA PHARMA/
VINEET LABORATORIES
 
P/E (TTM) x 17.9 -11.5 - View Chart
P/BV x 4.5 1.4 328.7% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 SHUKRA PHARMA   VINEET LABORATORIES
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-24
VINEET LABORATORIES
Mar-24
SHUKRA PHARMA/
VINEET LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9789 109.1%   
Low Rs1142 26.8%   
Sales per share (Unadj.) Rs68.0163.3 41.7%  
Earnings per share (Unadj.) Rs16.91.1 1,518.4%  
Cash flow per share (Unadj.) Rs18.83.8 488.4%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %1.80-  
Book value per share (Unadj.) Rs52.637.7 139.6%  
Shares outstanding (eoy) m10.969.22 118.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.80.4 199.0%   
Avg P/E ratio x3.258.6 5.5%  
P/CF ratio (eoy) x2.917.0 17.0%  
Price / Book Value ratio x1.01.7 59.4%  
Dividend payout %5.90-   
Avg Mkt Cap Rs m593602 98.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5064 78.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7461,506 49.5%  
Other income Rs m285 608.0%   
Total revenues Rs m7741,511 51.2%   
Gross profit Rs m19472 269.5%  
Depreciation Rs m2125 81.4%   
Interest Rs m348 6.0%   
Profit before tax Rs m1994 5,477.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m13-7 -202.7%   
Profit after tax Rs m18510 1,805.0%  
Gross profit margin %26.04.8 544.2%  
Effective tax rate %6.8-182.8 -3.7%   
Net profit margin %24.90.7 3,644.6%  
BALANCE SHEET DATA
Current assets Rs m562882 63.8%   
Current liabilities Rs m142760 18.6%   
Net working cap to sales %56.48.1 697.0%  
Current ratio x4.01.2 342.4%  
Inventory Days Days04 0.0%  
Debtors Days Days1,200766 156.6%  
Net fixed assets Rs m216287 75.3%   
Share capital Rs m10992 118.7%   
"Free" reserves Rs m467255 183.1%   
Net worth Rs m576347 166.0%   
Long term debt Rs m2739 68.4%   
Total assets Rs m7781,169 66.6%  
Interest coverage x70.81.1 6,577.1%   
Debt to equity ratio x00.1 41.2%  
Sales to assets ratio x1.01.3 74.4%   
Return on assets %24.25.0 486.6%  
Return on equity %32.23.0 1,087.3%  
Return on capital %33.413.3 251.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m0153 0.0%   
Net fx Rs m0-153 -0.0%   
CASH FLOW
From Operations Rs m-52-114 45.5%  
From Investments Rs m-123 -360.7%  
From Financial Activity Rs m124107 116.0%  
Net Cashflow Rs m60-4 -1,490.8%  

Share Holding

Indian Promoters % 51.0 36.1 141.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 63.9 76.7%  
Shareholders   16,321 10,300 158.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on RELISH PHARMA vs VINEET LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs VINEET LABORATORIES Share Price Performance

Period RELISH PHARMA VINEET LABORATORIES S&P BSE HEALTHCARE
1-Day 1.06% 2.62% 1.23%
1-Month -11.94% -6.53% -0.24%
1-Year 165.72% -23.69% 43.62%
3-Year CAGR 172.08% -11.97% 20.35%
5-Year CAGR 84.67% 1.73% 26.24%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the VINEET LABORATORIES share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of VINEET LABORATORIES the stake stands at 36.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of VINEET LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 5.9%.

VINEET LABORATORIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of VINEET LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.